Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition?
Publication
, Journal Article
Motter, JN; Devanand, DP; Doraiswamy, PM; Sneed, JR
Published in: Front Aging Neurosci
2016
Duke Scholars
Published In
Front Aging Neurosci
DOI
ISSN
1663-4365
Publication Date
2016
Volume
8
Start / End Page
249
Location
Switzerland
Related Subject Headings
- 5202 Biological psychology
- 3209 Neurosciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Motter, J. N., Devanand, D. P., Doraiswamy, P. M., & Sneed, J. R. (2016). Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition? Front Aging Neurosci, 8, 249. https://doi.org/10.3389/fnagi.2016.00249
Motter, Jeffrey N., Davangere P. Devanand, P Murali Doraiswamy, and Joel R. Sneed. “Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition?” Front Aging Neurosci 8 (2016): 249. https://doi.org/10.3389/fnagi.2016.00249.
Motter JN, Devanand DP, Doraiswamy PM, Sneed JR. Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition? Front Aging Neurosci. 2016;8:249.
Motter, Jeffrey N., et al. “Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition?” Front Aging Neurosci, vol. 8, 2016, p. 249. Pubmed, doi:10.3389/fnagi.2016.00249.
Motter JN, Devanand DP, Doraiswamy PM, Sneed JR. Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition? Front Aging Neurosci. 2016;8:249.
Published In
Front Aging Neurosci
DOI
ISSN
1663-4365
Publication Date
2016
Volume
8
Start / End Page
249
Location
Switzerland
Related Subject Headings
- 5202 Biological psychology
- 3209 Neurosciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 0601 Biochemistry and Cell Biology